» Articles » PMID: 28917088

Depression, Anxiety, PTSD and Comorbidity in Perinatal Women in Turkey: A Longitudinal Population-based Study

Overview
Journal Midwifery
Date 2017 Sep 17
PMID 28917088
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: (a) to assess prevalence of depression, anxiety and post-traumatic stress disorder (PTSD) and their comorbidity among women during the perinatal period (b) to examine course of those disorders from pregnancy to 6 months postpartum (c) to determine the rates of new-onset cases at 4-6 weeks and 6 months postpartum.

Design: A longitudinal population-based study in which participants completed psychosocial measures of depression, anxiety and PTSD in pregnancy (n = 950), 4-6 weeks (n = 858) and 6 months (n = 829) after birth.

Setting: A consecutive sample of pregnant women were recruited from three maternity hospitals in three cities of Turkey: Istanbul, Ankara and Izmir.

Measures: Edinburgh Postnatal Depression Scale (EPDS), Hospital Anxiety and Depression Scale (HADS), and Posttraumatic Diagnostic Scale (PDS) were used to assess depression, anxiety and PTSD, respectively.

Findings: Depression and PTSD peaked at 4-6 weeks postpartum and then fell at 6 months postpartum, whereas anxiety followed a gradually declining linear-pattern from pregnancy to 6 months postpartum. The prevalence of depression was 14.6% in pregnancy, 32.6% at 4-6 weeks and 18.5% at 6 months postpartum, respectively. The prevalence of PTSD was 5.8% in pregnancy, 11.9% at 4-6 weeks postpartum and 9.2% at 6 months postpartum. Anxiety was highest in pregnancy (29.6%) and then decreased to 24.6% 4-6 weeks after birth and to 16.2% 6 months after birth. New-onset cases were most apparent at 4-6 weeks postpartum: 24.6% for depression; 13.7% for anxiety and 8.9% for PTSD.

Key Conclusions: A relatively high prevalence of psychological disorders was identified during the perinatal period. Anxiety was most prevalent in pregnancy, and depression and PTSD were highest at 4-6 weeks postpartum. Depression was more common than anxiety 4-6 weeks and 6 months after birth and highly comorbid with anxiety throughout this period. New-onset cases were observed at both 4-6 weeks and 6 months postpartum.

Implications: High rates of affective disorders in pregnancy and after birth highlight three main points: first, it is important to have effective perinatal screening to identify women with psychological needs; second, providing early treatment to women experiencing severe psychological problems is essential to ensure psychological well-being of those women and to prevent chronicity; and finally, psychosocial screening and interventions should be offered until at least 6 months after birth to catch new-onset cases.

Citing Articles

Prevalence of perinatal post-traumatic stress disorder (PTSD) in low-income and middle-income countries: a systematic review and meta-analysis.

Jenkins H, Daskalopoulou Z, Opondo C, Alderdice F, Fellmeth G BMJ Public Health. 2025; 2(1):e000215.

PMID: 40018104 PMC: 11812746. DOI: 10.1136/bmjph-2023-000215.


A prospective cohort study of the association between mode of delivery and postpartum posttraumatic stress disorder.

Xu B, Chen Y, Tang J Sci Rep. 2025; 15(1):4149.

PMID: 39900967 PMC: 11790957. DOI: 10.1038/s41598-025-88717-7.


Treatment and counselling preferences of postpartum women with and without symptoms of (childbirth-related) PTSD: findings of the cross-sectional study INVITE.

Horstmann R, Seefeld L, Schellong J, Garthus-Niegel S BMC Pregnancy Childbirth. 2024; 24(1):885.

PMID: 39736602 PMC: 11686938. DOI: 10.1186/s12884-024-07061-2.


The association between social support and postpartum post-traumatic stress disorder.

Chen J, Wang S, Lai X, Zou L, Wen S, Krewski D BMC Pregnancy Childbirth. 2024; 24(1):874.

PMID: 39732666 PMC: 11682629. DOI: 10.1186/s12884-024-07088-5.


Impact of anemia on the six-month trend of anxiety and depression in women with threatened abortion: A case-control retrospective cohort study.

Mahboobeh Mirtabar S, Barat S, Kheirkhah F, Mostafazadeh A, Shirafkan H, Pahlavan Z Caspian J Intern Med. 2024; 16(1):158-164.

PMID: 39619753 PMC: 11607115. DOI: 10.22088/cjim.16.1.158.